Agilent Technologies Inc. (NYSE: A) today introduced new application compendiums on designer drug testing and toxicology of oral fluids. Also available is an expanded GC/MS Designer Drug Library. The only resource of its kind, this searchable library includes designer stimulants that are often marketed as “bath salts” as well as additional cannabinoid compounds. In tandem with the release of these new resources, Agilent is sponsoring monthly webinars featuring industry experts who will discuss new LC/MS and MS applications for forensic detection and analysis of designer drugs and metabolites. “Designer drugs—especially bath salts—continue to make headlines across the country,” said Tom Gluodenis, Agilent’s global marketing manager of Forensics and Toxicology. “The important resources we’re introducing today, used in collaboration with our specialized GC/MS laboratory technologies, provide forensic practitioners, crime laboratories, and federal workplace drug-testing programs with cost-effective, end-to-end solutions for designer drug screening and analysis.” Designer drugs are formulated to get around existing definitions of illicit compounds. Once difficult to trace, these substances can now be quickly identified and analyzed using Agilent’s GC/MS technologies. Agilent’s expanded application compendium, “Identification of Synthetic Cannabinoids in Herbal Incense Blends by GC/MS,” contains information on 45 cannabinoids and describes how to facilitate rapid screening and identification of these marijuana-like compounds. A companion compendium, “Analysis of Designer Stimulants by GC/MS,” describes the analysis of 30 stimulants. Agilent developed these compendiums, and the expanded GC/MS Designer Drug Library, in collaboration with NMS Labs. Screening oral fluid is an accurate and effective alternative to screening urine or blood. It provides many collection advantages, and samples can be more easily analyzed using highly sensitive enzyme immunoassays and LC-MS/MS instrumentation. Agilent’s updated oral fluid compendium, “Drugs and Metabolites in Oral Fluid: Immunoassay Screening and LC/MS/MS Confirmation and Quantification,” is a comprehensive treatise on the detection of drugs of abuse in oral fluid, covering 100 drugs in 11 classes.